Beijing Yanjing Brewery Co Ltd

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.04, indicating minimal leverage. Its liquidity position is characterized by a current ratio of 1.62, suggesting moderate short-term liquidity. However, the firm has negative net cash after subtracting total debt, which raises some liquidity concerns. In terms of profitability, the company's return on equity (ROE) is 10.85%, and its return on assets (ROA) is 7.07%. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and equity returns. The gross profit margin stands at 37.2%, and the operating margin is 15.4%, both of which are consistent with the industry's expectations for brewers. Geographically, the company's revenue is concentrated in China, with no significant international exposure disclosed. The firm's revenue is primarily derived from the sale of beer, with no material diversification into other beverage categories. This concentration may expose the company to regional economic and regulatory risks. The company's revenue for the latest period is 15.33 billion CNY, and its growth trajectory is expected to remain stable in the near term. Analysts have provided a mean price target of 15.43 CNY and a median price target of 16.35 CNY, with a mean recommendation of 1.85, indicating a generally positive outlook. The firm's operating cash flow of 2.72 billion CNY and free cash flow of 562.92 million CNY support its ability to fund operations and invest in growth. The company faces moderate liquidity risk and low dilution risk. The risk assessment indicates that the firm's liquidity is medium, and the potential for dilution is low. No significant dilution events have been identified in the recent filings or transcripts. The firm's capital expenditure of -1.27 billion CNY suggests a reduction in capital spending, which may be a strategic move to preserve cash. Recent events, including analyst estimates and price targets, suggest a cautiously optimistic outlook for the company. The firm has received a total of 5 strong-buy recommendations, 6 buy recommendations, and 1 hold recommendation from analysts, indicating a generally favorable sentiment. No major recent filings or transcripts have been identified that would significantly alter the company's risk profile.